WAM
HRMY icon

Weiss Asset Management’s Harmony Biosciences HRMY Stock Holding History

Weiss Asset Management’s Portfolio HRMY Stock Details HRMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$10M Buy
+275,829
New +$8.7M 0.11% 150
2025
Q3 		– Sell
-58,102
Closed -$1.84M – 690
2025
Q2 		$1.84M Buy
+58,102
New +$1.87M 0.02% 257

Other funds holding HRMY

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Weiss Asset Management's HRMY Position: Q2 2026 in Review

Weiss Asset Management opened a new position in Harmony Biosciences (HRMY) in Q2 2026: 275,829 shares worth $10M. The stake represents 0.11% of the portfolio and ranks #150 among its holdings. This is a return to the name: Weiss Asset Management previously reported a position in HRMY as recently as Q2 2025.

Weiss Asset Management first reported a position in HRMY in Q2 2025 and has held it in 2 quarters since. 328 funds tracked by Wall St. Rank hold HRMY as of Q2 2026.

  • Weiss Asset Management held 275,829 shares of Harmony Biosciences worth $10M as of Q2 2026.
  • Harmony Biosciences was a new Weiss Asset Management position in Q2 2026.
  • Harmony Biosciences made up 0.11% of Weiss Asset Management's portfolio in Q2 2026, its #150 holding.
  • Weiss Asset Management first reported a position in Harmony Biosciences in Q2 2025 and has held it in 2 quarters since.
  • 328 funds tracked by Wall St. Rank held Harmony Biosciences as of Q2 2026.

Based on Weiss Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.